281P Cyclin-dependent kinase 4/6 inhibitors combined with endocrine therapy for hormonal receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: A meta-analysis of randomized clinical trials

Autor: Alves, V.F.C., Moraes, F.C.A., Gomes, G.D.C., Almeida, G.D.O., Carnevalli, S., Priantti, J.N., Madeira, T.M., Vilbert, M. Silveira, Stecca, C.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S296-S296
Databáze: ScienceDirect